PQA and research partners at the University of Arizona, the University of Health Sciences and Pharmacy in St. Louis, and Merck & Co. recently conducted patient interviews to explore patients’ perceptions of their experience with comprehensive medication reviews (CMR).  

This work was published in the December 2024 issue of the Journal of Managed Care & Specialty Pharmacy. 

A total of 42 patients from diverse backgrounds were interviewed, which led to the creation of a conceptual framework intended to amplify the patient’s voice and enable patient-centered quality improvement for CMR delivery. 

The framework represents aspects of the CMR service that were most meaningful to patients, including: 

These findings are illustrated in the article using the quality improvement constructs of structure-process-outcome to depict how CMR providers can apply this information to real-world quality improvement efforts. 

This work built upon previous CMR-focused research by the same research team, which focused on real-world CMR delivery and quality including a scoping review, analysis of CMR transcripts, interviews with key stakeholders, and the production of a checklist to improve the consistency of CMRs. 

PQA and its research partners have leveraged these efforts to create a patient-reported outcome tool to assess patients’ medication knowledge, ability to self-manage their medication regimen, and address their questions and concerns. 

These efforts were described in a PQA Medication Therapy Management (MTM) Advisory Group meeting. The group was launched in September 2024 to gain stakeholder feedback, consensus, and momentum to address short- and long-term objectives to advance MTM service quality and measurement. Participation in the group is open to any individual at a PQA member organization. Individuals interested in joining the group should complete the group participation request form.